Rheumatoid arthritis medication linked to increased risk for shinglesFebruary 18th, 2009 - 5:21 pm ICT by ANI
Washington, February 18 (ANI): A new study suggests that there is an association between medications known as monoclonal antitumour necrosis factor a (TNF-a), which are used for treating rheumatoid arthritis, and an increased risk for herpes zoster (shingles), the painful infection characterized by blisters.
Appearing in the journal JAMA, a research article says that there has been evidence from some studies that patients treated with antiTNF-a agents are at an increased risk of bacterial infections, but little is known about the risk of viral infections, such as herpes zoster, in patients with rheumatoid arthritis receiving these types of medications.
According to background information in the article, Herpes zoster is one of the most common adverse events reported in clinical trials of antiTNF-a agents.
Dr. Anja Strangfeld, of the German Rheumatism Research Center in Berlin, says that patients with rheumatoid arthritis are at increased risk of herpes zoster as compared with the general population.
During the study, Strangfelds team investigated the association of various rheumatoid arthritis treatments, including antiTNF-a therapy, with the risk of herpes zoster.
The researchers analysed data from patients who began treatment with adalimumab or infliximab (monoclonal antiTNF-a antibodies), etanercept (a fusion protein), the monotherapeutic agent anakinra, or when patients changed conventional disease-modifying anti-rheumatic drug (DMARD).
Rheumatologists assessed treatment, clinical status and adverse events at fixed points during follow-up (of up to three years). A total of 5,040 patients were included in the analysis.
The researchers observed that there were 86 cases of herpes zoster among 82 patients.
According to them, 39 occurrences could be attributed to treatment with antiTNF-a antibodies.
The researchers found a significant association between herpes zoster and treatment with the monoclonal antiTNF-a antibodies infliximab and adalimumab, although this risk was lower than the threshold for clinical significance.
There seemed to be no significant association between herpes zoster and treatment with etanercept, or antiTNF-a treatment as a class.
The researchers found a significantly higher risk of developing herpes zoster for patients of older age and for treatment with glucocorticoids, steroid hormones that are widely used as anti-inflammatory medications.
“Based on our data, we recommend careful monitoring of patients treated with monoclonal antiTNF-a antibodies for early signs and symptoms of herpes zoster,” the authors conclude. (ANI)
- New drug restores responsiveness to morphine - Jan 31, 2011
- Smoking accounts for more than a third of severe rheumatoid arthritis cases - Dec 14, 2010
- Bone marrow cancer drug could be used to treat rheumatoid arthritis - Nov 04, 2010
- Lifetime risk of adult rheumatoid arthritis determined - Jan 06, 2011
- Just four out of ten patients know they have genital herpes - Apr 12, 2011
- Obesity epidemic behind rheumatoid arthritis - Apr 26, 2012
- New biomarker may help doctors tailor treatment for arthritis patients - Jan 30, 2010
- Positive outcomes in rheumatoid arthritis linked to early diagnosis - Nov 24, 2010
- Heavy snoring doubles arthritis risk - Jun 28, 2012
- Life work culminates in testing of cancer therapy in humans - Mar 24, 2011
- Frequent tipple halves rheumatoid arthritis risk - Jul 11, 2012
- New therapy shows promising result for HER2-positive metastatic disease - Oct 09, 2010
- Engineered protein has potential for new anti- inflammatory treatment - Mar 11, 2011
- 'Bouncer' protein halts rheumatoid arthritis - Sep 22, 2011
- Low socioeconomic status 'ups depression risk in rheumatoid arthritis patients' - Jan 27, 2011
Tags: adalimumab, adverse events, anakinra, antibodies, arthritis medication, bacterial infections, blisters, fusion protein, herpes, herpes zoster shingles, infliximab, journal jama, necrosis factor, patients with rheumatoid arthritis, research article, rheumatism, rheumatoid arthritis, rheumatoid arthritis treatments, tnf, viral infections